Connect with Bio Usawa’s CEO, Dr. Mengis Bairu, at Panel Sessions on Sunday and Tuesday

Kigali, Rwanda — November 02, 2025 — Bio Usawa’s CEO and President, Dr. Menghis Bairu, will be a panelist for two exciting sessions at this year’s AORTIC Conference in Tunisia. Please connect with him during the Conference at the sessions, or through [email protected].

Sunday, 2 November 2025: 14:00-16:00 - PANEL: Current Clinical Trial Training Programs in Africa (Plenary Room)
Tuesday, 4 November 2025: 15:00-17:00 – PANEL: Digital Technology Platforms, Affordable Technologies and Innovative Therapies (Hall 4).

About Bio Usawa

Bio Usawa is Africa’s pioneering biotechnology company dedicated to democratizing access to life-saving biotherapeutics. Headquartered in Kigali, Rwanda, the company develops, licenses, and manufactures affordable monoclonal antibodies and biosimilars targeting cancer, diabetes complications, infectious diseases, and autoimmune conditions.